Do Interactions Between Environmental Chemicals and the Human Microbiome Need to Be Considered in Risk Assessments?

One of the most dynamic and fruitful areas of current health‐related research concerns the various roles of the human microbiome in disease. Evidence is accumulating that interactions between substances in the environment and the microbiome can affect risks of disease, in both beneficial and adverse ways. Although most of the research has concerned the roles of diet and certain pharmaceutical agents, there is increasing interest in the possible roles of environmental chemicals. Chemical risk assessment has, to date, not included consideration of the influence of the microbiome. We suggest that failure to consider the possible roles of the microbiome could lead to significant error in risk assessment results. Our purpose in this commentary is to summarize some of the evidence supporting our hypothesis and to urge the risk assessment community to begin considering and influencing how results from microbiome‐related research could be incorporated into chemical risk assessments. An additional emphasis in our commentary concerns the distinct possibility that research on chemical–microbiome interactions will also reduce some of the significant uncertainties that accompany current risk assessments. Of particular interest is evidence suggesting that the microbiome has an influence on variability in disease risk across populations and (of particular interest to chemical risk) in animal and human responses to chemical exposure. The possible explanatory power of the microbiome regarding sources of variability could reduce what might be the most significant source of uncertainty in chemical risk assessment.     

Microbiota and Dose Response: Evolving Paradigm of Health Triangle

SRA Dose‐Response and Microbial Risk Analysis Specialty Groups jointly sponsored symposia that addressed the intersections between the “microbiome revolution” and dose response. Invited speakers presented on innovations and advances in gut and nasal microbiota (normal microbial communities) in the first decade after the Human Microbiome Project began. The microbiota and their metabolites are now known to influence health and disease directly and indirectly, through modulation of innate and adaptive immune systems and barrier function. Disruption of healthy microbiota is often associated with changes in abundance and diversity of core microbial species (dysbiosis), caused by stressors including antibiotics, chemotherapy, and disease. Nucleic‐acid‐based metagenomic methods demonstrated that the dysbiotic host microbiota no longer provide normal colonization resistance to pathogens, a critical component of innate immunity of the superorganism. Diverse pathogens, probiotics, and prebiotics were considered in human and animal models (in vivo and in vitro ). Discussion included approaches for design of future microbial dose–response studies to account for the presence of the indigenous microbiota that provide normal colonization resistance , and the absence of the protective microbiota in dysbiosis. As NextGen risk analysis methodology advances with the “microbiome revolution,” a proposed new framework, the Health Triangle, may replace the old paradigm based on the Disease Triangle (focused on host, pathogen, and environment) and germophobia. Collaborative experimental designs are needed for testing hypotheses about causality in dose–response relationships for pathogens present in our environments that clearly compete in complex ecosystems with thousands of bacterial species dominating the healthy superorganism.     

Cultural epigenetics

Taking a Waddingtonian system approach, I discuss some of the implications of recent epigenetic research for the study of social systems. A growing number of investigations show that life-style changes resulting from nutritional, toxicological, and psychological stresses are reflected in changes in the epigenetic profile of individuals, and that learning and memory have epigenetic correlates. Moreover, various types of epigenetic changes can be inherited and affect the characters of descendants. Studying epigenetics can forge new experimental and conceptual bridges between biology, the social sciences and the humanities. For example, new techniques that allow the deciphering of methylation patterns in ancient DNA could be used to study the epigenetics of human cultures in long-gone historical periods, thus enriching and extending our knowledge of human history. Conceptually, an epigenetic perspective blurs traditional distinctions such as those between nature and nurture, plasticity and evolvability.     

Tuning parameter selection for a penalized estimator of species richness

Our goal is to estimate the true number of classes in a population, called the species richness. We consider the case where multiple frequency count tables have been collected from a homogeneous population and investigate a penalized maximum likelihood estimator under a negative binomial model. Because high probabilities of unobserved classes increase the variance of species richness estimates, our method penalizes the probability of a class being unobserved. Tuning the penalization parameter is challenging because the true species richness is never known, and so we propose and validate four novel methods for tuning the penalization parameter. We illustrate and contrast the performance of the proposed methods by estimating the strain-level microbial diversity of Lake Champlain over three consecutive years, and global human host-associated species-level microbial richness.